Effects of estradiol-drospirenone on ocular and nasal functions in postmenopausal women

ÇOKSUER H., ÖZCURA F., OĞHAN F., Haliloglu B., ÇOKSUER C.

CLIMACTERIC, cilt.14, sa.4, ss.482-487, 2011 (SCI-Expanded, Scopus)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 14 Sayı: 4
  • Basım Tarihi: 2011
  • Doi Numarası: 10.3109/13697137.2010.539724
  • Dergi Adı: CLIMACTERIC
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.482-487
  • Anahtar Kelimeler: HORMONE REPLACEMENT THERAPY, DROSPIRENONE, ANGELIQ, DRY EYE, OCULAR DISEASE, NASAL AIRFLOW, HORMONE REPLACEMENT THERAPY, DRY EYE, LENS OPACITIES, RHINOMANOMETRIC OUTCOMES, REPRODUCTIVE FACTORS, MG DROSPIRENONE, TEAR FUNCTION, ESTROGEN, MENOPAUSE, AGE
  • Kütahya Sağlık Bilimleri Üniversitesi Adresli: Hayır

Özet

Background Hormones may have an impact on the incidence and course of dry-eye syndrome, and also nasal obstruction, especially in postmenopausal women. The aim of this study was to investigate the effects of drospirenone 2 mg + estradiol 1 mg (Angeliq (R), Bayer AG, Berlin, Germany) on ocular functions and nasal airflow in postmenopausal women.